Recombinant Human DEFB118 Protein，His

Defensin Beta 118 (DEFB118) is a member of the human defensin family, which plays a crucial role in the innate immune system. These small cationic peptides are primarily expressed in the epithelial tissues and serve as antimicrobial agents, providing the first line of defense against a variety of pathogens, including bacteria, viruses, and fungi. DEFB118 specifically is known for its ability to disrupt microbial membranes, making it a potential candidate for antimicrobial therapy. Research into DEFB118 has gained momentum owing to its promising therapeutic applications, especially in the context of increasing antibiotic resistance. Furthermore, studies have suggested that DEFB118 may also have immunomodulatory functions, influencing inflammation and wound healing processes. Given its multifaceted roles in host defense and potential clinical applications, understanding the structure, function, and regulation of DEFB118 through recombinant protein production has become a significant focus of research. By utilizing recombinant DNA technology to produce DEFB118, scientists aim to explore its functional mechanisms, optimize its antimicrobial properties, and investigate its potential as a therapeutic agent in treating infectious diseases and enhancing immune responses. This growing body of research underscores the importance of DEFB118 in both basic immunology and applied biomedical science.